Does DEUCRAVACITINIB Cause Psoriasis? 122 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Psoriasis have been filed in association with DEUCRAVACITINIB (SOTYKTU). This represents 5.1% of all adverse event reports for DEUCRAVACITINIB.
122
Reports of Psoriasis with DEUCRAVACITINIB
5.1%
of all DEUCRAVACITINIB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Psoriasis From DEUCRAVACITINIB?
Of the 122 reports, 2 (1.6%) required hospitalization.
Is Psoriasis Listed in the Official Label?
Yes, Psoriasis is listed as a known adverse reaction in the official FDA drug label for DEUCRAVACITINIB.
What Other Side Effects Does DEUCRAVACITINIB Cause?
Drug ineffective (228)
Acne (225)
Pruritus (187)
Rash (175)
Erythema (124)
Off label use (101)
Adverse event (74)
Mouth ulceration (72)
Folliculitis (65)
Headache (65)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
RISANKIZUMAB-RZAA (6,896)
METHOTREXATE (6,283)
USTEKINUMAB (4,955)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
Which DEUCRAVACITINIB Alternatives Have Lower Psoriasis Risk?
DEUCRAVACITINIB vs DEUTETRABENAZINE
DEUCRAVACITINIB vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DEUCRAVACITINIB vs DEVICE
DEUCRAVACITINIB vs DEXAMETHASONE
DEUCRAVACITINIB vs DEXAMETHASONE\DEXAMETHASONE